Literature DB >> 18835251

Nck-1 interacts with PKR and modulates its activation by dsRNA.

Eric Cardin1, Louise Larose.   

Abstract

Activation of the double-stranded RNA (dsRNA)-activated protein kinase PKR results in inhibition of general translation through phosphorylation of the eukaryotic initiation factor 2 alpha-subunit on serine 51 (eIF2alphaSer51). Previously, we have reported that the adaptor protein Nck-1 modulates eIF2alphaSer51 phosphorylation by a subset of eIF2alpha kinases, including PKR. Herein, we demonstrate that Nck-1 prevents efficient activation of PKR by dsRNA, revealing that Nck-1 acts at the level of PKR. In agreement, Nck-1 impairs p38MAPK activation and attenuates cell death induced by dsRNA, in addition to diminish eIF2alphaSer51 phosphorylation. Our data show that the inhibitory effect of Nck-1 on PKR is reversible, as it could be overcome by increasing levels of dsRNA. Interestingly, we found that Nck-1 interacts with the inactive form of PKR, independently of its Src homology domains. Furthermore, we uncovered that Nck-1 is substrate of PKR in vitro. All together, our data provide the first evidence identifying Nck-1 as a novel endogenous regulator of PKR and support the notion that Nck-1-PKR interaction could be a way to limit PKR activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835251     DOI: 10.1016/j.bbrc.2008.09.112

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  West Nile virus infection does not induce PKR activation in rodent cells.

Authors:  H Elbahesh; S V Scherbik; M A Brinton
Journal:  Virology       Date:  2011-10-07       Impact factor: 3.616

2.  Nck adapter proteins: functional versatility in T cells.

Authors:  Marcus Lettau; Jennifer Pieper; Ottmar Janssen
Journal:  Cell Commun Signal       Date:  2009-02-02       Impact factor: 5.712

3.  Candidates for tumor markers of cervical cancer discovered by proteomic analysis.

Authors:  Jae Yun Song; Hyo Sook Bae; Do Hyoung Koo; Jae Kwan Lee; Hak Hyun Jung; Kyu Wan Lee; Nak Woo Lee
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.